{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigqxka3sq2duxqmzhus5zyggbvjqiri2byee3wvnaehflfm4xp3yy",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mlrvi2kayym2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibmny2zb3ooervvvxefb3xkhdx6aedi3isqpvrrvwjsqjwzxavqsa"
    },
    "mimeType": "image/jpeg",
    "size": 729356
  },
  "path": "/news/2026-05-popular-weight-loss-anti-inflammatory.html",
  "publishedAt": "2026-05-13T23:40:02.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Researchers at Ben-Gurion University of the Negev (BGU) have identified how two different classes of medication—the GLP-1 receptor agonist semaglutide and the anti-inflammatory drug colchicine—act on the heart to prevent the development of Atrial Fibrillation (AF). The study, published in Europace, provides a clearer biological map of how these drugs protect the heart's structure and electrical signaling, potentially offering new ways to treat patients before AF takes hold.",
  "title": "Popular weight loss and anti-inflammatory drugs may help prevent common heart rhythm disorder"
}